Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota

(2015) C. T. Peterson et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD

(2015) Chong He et al.   GUT

IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function

(2015) Amanda Waddell et al.   INFLAMMATORY BOWEL DISEASES

Regulatory immune cells in regulation of intestinal inflammatory response to microbiota

(2015) M Sun et al.   Mucosal Immunology

IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactions

(2015) Laurel A. Monticelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-33-Mediated Protection against Experimental Cerebral Malaria Is Linked to Induction of Type 2 Innate Lymphoid Cells, M2 Macrophages and Regulatory T Cells

(2015) Anne-Gaelle Besnard et al.   PLoS Pathogens

Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33

(2014) A. M. Shadie et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD

(2014) Wei Wu et al.   GUT

The alarmin IL-33 promotes regulatory T-cell function in the intestine

(2014) Chris Schiering et al.   NATURE

Protective Role of Oligomycin Against Intestinal Epithelial Barrier Dysfunction Caused by IFN-? and TNF-a

(2013) Hang Liu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease

(2013) C. Liu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome

(2013) Dan Knights et al.   GUT

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

(2013) M Zaeem Cader et al.   GUT

The Role of IL-33 in Gut Mucosal Inflammation

(2013) Luca Pastorelli et al.   MEDIATORS OF INFLAMMATION

Hypoxia-Inducible Factor-1α and Interleukin 33 Form a Regulatory Circuit to Perpetuate the Inflammation in Rheumatoid Arthritis

(2013) Fanlei Hu et al.   PLoS One

Microbiota regulation of inflammatory bowel disease and colorectal cancer

(2013) Zhanju Liu et al.   SEMINARS IN CANCER BIOLOGY

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages

(2012) Hui-Rong Jiang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-33 attenuates development and perpetuation of chronic intestinal inflammation

(2012) Philipp Gro et al.   INFLAMMATORY BOWEL DISEASES

Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa

(2012) E. T. Clambey et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1

(2011) Eric V. Dang et al.   CELL

Hydroxylase Inhibition Abrogates TNF- -Induced Intestinal Epithelial Damage by Hypoxia-Inducible Factor-1-Dependent Repression of FADD

(2010) P. Hindryckx et al.   JOURNAL OF IMMUNOLOGY

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

(2010) Luca Pastorelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-33 is upregulated in colonocytes of ulcerative colitis

(2009) Jakob Benedict Seidelin et al.   IMMUNOLOGY LETTERS

Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease

(2009) Caroll J. Beltrán et al.   INFLAMMATORY BOWEL DISEASES